Follow the companies advancing digital health, diagnostics, drug discovery, and biotech platforms across APAC.
Regulatory approvals and clinical milestones in APAC markets often surface through local-language official channels first.
Partnership and licensing signals between biotech companies cluster earlier here than in English-language industry reports.
This channel is useful for tracking both established pharma companies and emerging biotech challengers.
This channel covers 6 strategic themes. Each theme represents a distinct area of company activity monitored through official sources.
Samsung Biologics and Eli Lilly to Establish New Gateway Labs in Korea
Halodoc Reaches 35 Million Monthly Active Users, Launches AI Triage in Indonesia
M3 Announces Share Repurchase Status Under Company Articles
BeiGene Announces Q4 and Full Year 2025 Financial Results
BeOne Medicines Announces Q4 and FY2025 Financial Results
Celltrion Commences Full-Scale CMO Production at U.S. Facility
Track clinical milestones, regulatory approvals, and competitive moves across healthtech players.
Build a structured view of the healthtech landscape across diagnostics, drug discovery, and digital health.
Monitor funding rounds, licensing deals, and strategic investment patterns in the healthtech ecosystem.
Get structured intelligence from official sources across languages — before it reaches the English web.